Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 12—December 2011

Research

Molecular Epidemiology of Rift Valley Fever Virus

Antoinette A. Grobbelaar, Jacqueline Weyer, Patricia A. Leman, Alan Kemp, Janusz T. Paweska, and Robert SwanepoelComments to Author 
Author affiliations: National Institute for Communicable Diseases of the National Health Service, Sandringham, South Africa (A.A. Grobbelaar, J. Weyer, P.A Leman, A. Kemp, J.T. Paweska, R. Swanepoel); University of Pretoria, Pretoria, South Africa (R. Swanepoel)

Main Article

Figure 1

Annual sales of Smithburn neurotropic strain animal vaccine produced in South Africa in relation to cumulative viral lineages isolated and human deaths in major outbreaks of Rift Valley fever (RVF) in Africa and Saudi Arabia, 1944–2010. Broken arrows indicate RVF outbreaks without human deaths recorded, and solid arrows indicate RVF outbreaks with human deaths. RSA, Republic of South Africa; NAM, Namibia; ZIM, Zimbabwe; MOZ, Mozambique; KEN, Kenya; EGY, Egypt; SUD, Sudan; ZAM, Zambia; MAU, Mauri

Figure 1. Annual sales of Smithburn neurotropic strain animal vaccine produced in South Africa in relation to cumulative viral lineages isolated and human deaths in major outbreaks of Rift Valley fever (RVF) in Africa and Saudi Arabia, 1944–2010. Broken arrows indicate RVF outbreaks without human deaths recorded, and solid arrows indicate RVF outbreaks with human deaths. RSA, Republic of South Africa; NAM, Namibia; ZIM, Zimbabwe; MOZ, Mozambique; KEN, Kenya; EGY, Egypt; SUD, Sudan; ZAM, Zambia; MAU, Mauritania; MAD, Madagascar; TAN, Tanzania; SOM, Somalia; SAU, Saudi Arabia; YEM, Yemen.

Main Article

TOP